EFSA and health claims DHA and EPA
Scientific Opinion on the substantiation of health claims related to docosahexaenoic acid (DHA), eicosapentaenoic acid (EPA) and brain, eye and nerve development, maintenance of normal brain function, maintenance of normal vision, maintenance of normal cardiac function, “maternal health; pregnancy and nursing”, “to fulfil increased omega-3 fatty acids need during pregnancy”, “skin and digestive tract epithelial cells maintenance”, enhancement of mood, “membranes cell structure”, “anti-inflammatory action” and maintenance of normal blood LDL-cholesterol concentrations pursuant to Article 13(1) of Regulation (EC) No 1924/2006 (published: EFSA 2011)
